Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D06UTH
|
||||
| Former ID |
DIB004090
|
||||
| Drug Name |
RDEA-684
|
||||
| Indication | Gout [ICD9: 274.00274.1274.8274.9; ICD10:M10] | Phase 2 | [1] | ||
| Company |
Ardea Biosciences Inc
|
||||
| Target and Pathway | |||||
| Target(s) | Solute carrier family 22 member 12 | Target Info | Inhibitor | [2] | |
| WikiPathways | Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds | ||||
| References | |||||
| REF 1 | ClinicalTrials.gov (NCT01927198) RDEA3170 Monotherapy in Subjects With Gout. U.S. National Institutes of Health. | ||||
| REF 2 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1031). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.